INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 257 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,349 | +28.2% | 35,340 | +38.1% | 0.00% | +50.0% |
Q2 2023 | $1,052 | +52.9% | 25,590 | +113.5% | 0.00% | 0.0% |
Q1 2023 | $688 | +24.6% | 11,986 | +21.7% | 0.00% | +100.0% |
Q4 2022 | $552 | -100.0% | 9,852 | -93.1% | 0.00% | -93.8% |
Q3 2022 | $6,057,000 | -24.2% | 142,989 | -3.3% | 0.02% | -20.0% |
Q2 2022 | $7,991,000 | +1125.6% | 147,897 | +1357.4% | 0.02% | +1900.0% |
Q1 2022 | $652,000 | +34.4% | 10,148 | +40.1% | 0.00% | 0.0% |
Q4 2021 | $485,000 | +46.5% | 7,243 | +49.6% | 0.00% | 0.0% |
Q3 2021 | $331,000 | +2.5% | 4,843 | +2.1% | 0.00% | 0.0% |
Q2 2021 | $323,000 | -1.5% | 4,743 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $328,000 | +10.8% | 4,743 | +3.9% | 0.00% | 0.0% |
Q4 2020 | $296,000 | +37.0% | 4,565 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $216,000 | -87.1% | 4,565 | -87.1% | 0.00% | -80.0% |
Q2 2020 | $1,670,000 | +118.0% | 35,525 | +107.2% | 0.01% | +66.7% |
Q1 2020 | $766,000 | -23.7% | 17,147 | -0.4% | 0.00% | 0.0% |
Q4 2019 | $1,004,000 | -2.9% | 17,209 | 0.0% | 0.00% | -25.0% |
Q3 2019 | $1,034,000 | +3.7% | 17,209 | -3.6% | 0.00% | +33.3% |
Q2 2019 | $997,000 | +4.6% | 17,847 | +4.4% | 0.00% | -25.0% |
Q1 2019 | $953,000 | +20.8% | 17,100 | -2.3% | 0.00% | +33.3% |
Q4 2018 | $789,000 | -64.5% | 17,500 | -48.1% | 0.00% | -62.5% |
Q3 2018 | $2,220,000 | -9.1% | 33,700 | -11.1% | 0.01% | -11.1% |
Q2 2018 | $2,441,000 | +11.7% | 37,900 | -4.1% | 0.01% | 0.0% |
Q1 2018 | $2,186,000 | +15.4% | 39,500 | -0.3% | 0.01% | +28.6% |
Q4 2017 | $1,895,000 | -29.3% | 39,600 | -25.4% | 0.01% | -36.4% |
Q3 2017 | $2,680,000 | -11.9% | 53,100 | -4.8% | 0.01% | -8.3% |
Q2 2017 | $3,042,000 | +29.0% | 55,800 | -0.4% | 0.01% | +20.0% |
Q1 2017 | $2,359,000 | -2.6% | 56,000 | +98.4% | 0.01% | -9.1% |
Q4 2016 | $2,422,000 | +12.0% | 28,230 | +7.7% | 0.01% | 0.0% |
Q3 2016 | $2,163,000 | +53975.0% | 26,200 | +33489.7% | 0.01% | – |
Q4 2013 | $4,000 | – | 78 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VeriStar Capital Management LP | 268,000 | $10,234,920 | 8.72% |
Madison Avenue Partners, LP | 964,667 | $36,840,633 | 5.23% |
Pavadi Capital LLC | 99,999 | $3,818,962 | 4.97% |
KESTREL INVESTMENT MANAGEMENT CORP | 122,450 | $4,676 | 2.96% |
Sapience Investments, LLC | 245,700 | $9,383,283 | 2.26% |
Ellsworth Advisors, LLC | 102,500 | $3,882,700 | 1.38% |
Point72 Europe (London) LLP | 464,462 | $17,737,804 | 1.09% |
COOKE & BIELER LP | 2,714,194 | $103,655,069 | 1.01% |
TANDEM CAPITAL MANAGEMENT CORP /ADV | 75,586 | $2,886,630 | 0.99% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,827 | $43,033,523 | 0.95% |